Special Meeting | Topic: MEDTRONIC – LEADING THE WAY IN DBS | Speaker: Michelle Morton Reed, Senior Deep Brain Stimulation (DBS) Therapy Expert at Medtronic
We are happy to announce that we have been able to reschedule our July speaker who had to cancel due to a family emergency and arrange a special meeting on Sunday, November 8, 2026. The topic of the new technology, Adaptive DBS, is especially interesting to many of us.
Same location and time as usual: Lexington Medical Park I, 2728 Sunset Blvd., West Columbia, SC 29169 – 3 PM
MEDTRONIC
LEADING THE WAY IN DBS
For the one million people diagnosed with Parkinson’s disease in the United States, Medtronic, a global leader in healthcare technology, proudly announces FDA approval of BrainSense™ Adaptive deep brain stimulation (aDBS) and BrainSense™ Electrode Identifier (EI).
Deep brain stimulation (DBS) has been transforming the lives of people with Parkinson’s and other neurological disorders for more than 30 years. DBS is similar to a cardiac pacemaker, but for the brain. It uses a surgically implanted neurostimulator via a minimally invasive procedure to transmit electrical signals to specific parts of the brain affected by debilitating neurological disorders. Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology, introducing aDBS for people living with Parkinson’s. This feature personalizes therapy based on a patient’s brain activity in real time – both in clinical settings and in daily life2. It provides enhanced therapy personalization for symptom control that automatically adjusts, minimizing the need for patients to manually adjust stimulation.
“Medtronic is the only company in the world to offer an adaptive DBS system that dynamically adjusts therapy in real time. This new era in Parkinson’s care represents more than a decade of intentional innovation ushering in personalized neuromodulation at scale that responds to a patient’s changing needs, equipping clinicians with unparalleled insights, and setting a new standard for DBS therapy.”
Contact: 710 Medtronic Parkway
Minneapolis, MN 55432-5640
Telephone: (800) 633-8766
http://www.medtronicdbs.com/
SPEAKER: MICHELLE MORTON REED
Michelle Morton Reed is a Senior Deep Brain Stimulation (DBS) Therapy Expert at Medtronic, with a Bachelor of Science in Exercise Science from the University of Texas at Arlington. Since 1999, Michelle has worked in the medical field in both clinical and commercial capacities, bringing over two decades of experience to her current role. She remains deeply committed to patient care and continues to find fulfillment in her daily interactions with individuals living with Parkinson’s disease.
Michelle is the proud mother of two children.
“My purpose is to make a meaningful impact in the lives of others. Working closely with Parkinson’s patients has shown me their strength, humility, and resilience. Nothing brings me more joy than knowing I’ve helped improve someone’s day even in the smallest way. For me, every patient interaction is a chance to make a difference and live out my calling.”